Frank Doyle September 26, 2016 Orbus Therapeutics Announces Enrollment of First Patient in Phase 3 Trial in Late-Stage Brain Cancer Frank Doyle September 26, 2016 READ FULL RELEASE
Teresa Long June 17, 2016 Orbus Therapeutics Granted Orphan Drug Designation by European Medicines Agency for Late Stage Brain Cancer Teresa Long June 17, 2016 Read Full Release
Teresa Long August 19, 2015 Orbus Therapeutics Secures $32.5 Million Series A Financing to Advance Late-Stage Brain Cancer Drug Teresa Long August 19, 2015 Read Full Release
